Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: A case series

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Diamantopoulos, Andreas P ^a,b   Hetland, Helene ^a   Myklebust, Geirmund ^a  

^a Southern Norway Hospital Trust   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LEFLUNOMIDE; PREDNISOLONE; CORTICOSTEROID; ISOXAZOLE DERIVATIVE;

AGED; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; FEMALE; GIANT CELL ARTERITIS; HUMAN; MALAISE; MALE; RASH; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; TREATMENT DURATION; CASE REPORT; DRUG EFFECT; GIANT CELL; MIDDLE AGED; PATHOLOGY;

ADRENAL CORTEX HORMONES; AGED; FEMALE; GIANT CELL ARTERITIS; GIANT CELLS; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA;

EID: 84884890438     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/120638     Document Type: Article

References (16)

1. Salvarani C., Cantini F., Hunder G. G., Polymyalgia rheumatica and giant-cell arteritis. The Lancet 2008 372 9634 234 245 2-s2.0-47349103031 10.1016/S0140-6736(08)61077-6 (Pubitemid 351997438)
2. Dasgupta B., Borg F. A., Hassan N., Barraclough K., Bourke B., Fulcher J., Hollywood J., Hutchings A., Kyle V., Nott J., Power M., Samanta A., BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology 2010 49 1 186 190 2-s2.0-77951969629
3. Hernández-Rodríguez J., Cid M. C., López-Soto A., Espigol-Frigolé G., Bosch X., Treatment of polymyalgia rheumatica: a systematic review. Archives of Internal Medicine 2009 169 20 1839 1850 2-s2.0-70449638401 10.1001/archinternmed.2009.352
4. De Silva M., Hazleman B. L., Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Annals of the Rheumatic Diseases 1986 45 2 136 138 2-s2.0-0022578244 (Pubitemid 16162481)
5. Mahr A. D., Jover J. A., Spiera R. F., Hernández-García C., Fernández-Gutiérrez B., LaValley M. P., Merkel P. A., Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis and Rheumatism 2007 56 8 2789 2797 2-s2.0-34547733910 10.1002/art.22754 (Pubitemid 47237299)
6. Schmidt J., Warrington K. J., Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management. Drugs & Aging 2011 28 8 651 666 2-s2.0-79961216379 10.2165/11592500-000000000- 00000
7. Smolen J. S., Landewé R., Breedveld F. C., Dougados M., Emery P., Gaujoux-Viala C., Gorter S., Knevel R., Nam J., Schoels M., Aletaha D., Buch M., Gossec L., Huizinga T., Bijlsma J. W. J. W., Burmester G., Combe B., Cutolo M., Gabay C., Gomez-Reino J., Kouloumas M., Kvien T. K., Martin-Mola E., McInnes I., Pavelka K., Van Riel P., Scholte M., Scott D. L., Sokka T., Valesini G., Van Vollenhoven R., Winthrop K. L., Wong J., Zink A., Van Der Heijde D., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases 2010 69 6 964 975 2-s2.0-77953696525 10.1136/ard.2009.126532
8. Gossec L., Smolen J. S., Gaujoux-Viala C., Ash Z., Marzo-Ortega H., Van Der Heijde D., FitzGerald O., Aletaha D., Balint P., Boumpas D., Braun J., Breedveld F. C., Burmester G., Cañete J. D., De Wit M., Dagfinrud H., De Vlam K., Dougados M., Helliwell P., Kavanaugh A., Kvien T. K., Landewé R., Luger T., Maccarone M., McGonagle D., McHugh N., McInnes I. B., Ritchlin C., Sieper J., Tak P. P., Valesini G., Vencovsky J., Winthrop K. L., Zink A., Emery P., European league against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Annals of the Rheumatic Diseases 2012 71 1 4 12 2-s2.0-82955236087 10.1136/annrheumdis-2011-200350
9. de Souza A. W. S., da Silva M. D., MacHado L. S. G., Oliveira A. C. D., Pinheiro F. A. G., Sato E. I., Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study. Scandinavian Journal of Rheumatology 2012 41 3 227 230 2-s2.0-84860545850 10.3109/03009742.2011.633553
10. Metzler C., Miehle N., Manger K., Iking-Konert C., de Groot K., Hellmich B., Gross W. L., Reinhold-Keller E., Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology 2007 46 7 1087 1091 2-s2.0-34447323863 10.1093/rheumatology/kem029 (Pubitemid 47050609)
11. Adizie T., Christidis D., Dharmapaliah C., Borg F., Dasgupta B., Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series. International Journal of Clinical Practice 2012 66 9 906 909
12. Kirsch B. M., Zeyda M., Stuhlmeier K., Grisar J., Smolen J. S., Watschinger B., Stulnig T. M., Hörl W. H., Zlabinger G. J., Säemann M. D., The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function. Arthritis Research & Therapy 2005 7 3 R694 703 2-s2.0-33644808414
13. González-Alvaro I., Ortiz A. M., Domínguez-Jiménez C., Aragón-Bodi A., Díaz Sánchez B., Sánchez-Madrid F., Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway. Annals of the Rheumatic Diseases 2009 68 10 1644 1650 2-s2.0-70349384718 10.1136/ard.2008.096743
14. Deng J., Younge B. R., Olshen R. A., Goronzy J. J., Weyand C. M., Th17 and th1 T-cell responses in giant cell arteritis. Circulation 2010 121 7 906 915 2-s2.0-77649157249 10.1161/CIRCULATIONAHA.109.872903
15. Hunder G. G., Bloch D. A., Michel B. A., Stevens M. B., Arend W. P., Calabrese L. H., Edworthy S. M., Fauci A. S., Leavitt R. Y., Lie J. T., Lightfoot R. W. Jr., Masi A. T., McShane D. J., Mills J. A., Wallace S. L., Zvaifler N. J., The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis and Rheumatism 1990 33 8 1122 1128 2-s2.0-0025103002 (Pubitemid 20273297)
16. Dasgupta B., Cimmino M. A., Kremers H. M., Schmidt W. A., Schirmer M., Salvarani C., Bachta A., Dejaco C., Duftner C., Jensen H. S., Duhaut P., Poõr G., Kaposi N. P., Mandl P., Balint P. V., Schmidt Z., Iagnocco A., Nannini C., Cantini F., MacChioni P., Pipitone N., Del Amo M., Espígol-Frigolé G., Cid M. C., Martínez-Taboada V. M., Nordborg E., Direskeneli H., Aydin S. Z., Ahmed K., Hazleman B., Silverman B., Pease C., Wakefield R. J., Luqmani R., Abril A., Michet C. J., Marcus R., Gonter N. J., Maz M., Carter R. E., Crowson C. S., Matteson E. L., 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis and Rheumatism 2012 64 4 943 954 2-s2.0-84857828277 10.1002/art.34356